Bavarian Biotech Report 2011/2012 (7MB) - Bio M

More documents

Recommendations

Info

ImprintEditorial staff: Georg Kääb, Bianca ReuterData collection: André Hansbauer, Sabine JordanCompany Profiles: André Hansbauer, Ivonne WagnerWe thank the Bavarian companies and the regionalorganizations of the Bavarian Biotechnology Clusterin supporting this survey.April, 2012ContactProf. Dr. Horst Domdey, Managing DirectorSpokesman of the Bavarian Biotechnology ClusterDr. Georg Kääb, Cluster ManagerThe Bavarian and the Munich Biotechnology Clusterare managed by:Bio M Biotech Cluster Development GmbHAm Klopferspitz 19aD-82152 MartinsriedPhone: +49 (0)89-899679-0Fax: +49 (0)89-899679-79E-Mail: info@bio-m.orgInternet: www.biotech-bavaria.deThe layout, graphics and other contents of this brochureof the Bavarian Biotechnology Cluster are protected bycopyright law.Layout-Design: aimcom, Munich, www.aimcom.dePicture credits: fotolia.com (Jan Felber, kreefax);istockphoto.comSupported by the Bavarian State Ministry of EconomicAffairs, Infrastructure, Transport and Technologywww.stmwivt.bayern.de/en/foreign-trade4
ContentThe Bavarian Biotechnology Cluster 07Prof. Dr. Horst Domdey – Speaker of the “Bavarian Biotechnology Cluster”The 2011 Biotech Year in Bavaria – And Beyond 08-14Facts and Figures 15-26Employment 17-18Jobs in Biotechnology CompaniesProducts and Pipeline 19-21Drug DevelopmentDeals, Cooperation, Mergers, Financing 22-26Deals and CooperationM&A-ActivityFinancingRevenuesSummaryIndustrial Biotechnology on the move 28-29Company Profiles 31-121in alphabetical orderAbout this survey:For the following report, a biotechnology company has been defined as a company, which develops and/ormanufactures products on the basis of state-of-the-art molecular biological methods. But as “conventional”pharmaceutical companies are increasingly also using such methods, it is often difficult to differentiatebetween biotech and pharma. Traditional phytopharmaceutical companies and manufacturers of homeopathicproducts are however not included in this compilation. We distinguished the parameters specific toeach sector and conducted separate surveys for biotech companies, pharmaceutical companies, (clinical)contract research organizations (CROs), contract manufacturing organizations (CMOs), suppliers andothers with activities in the biotechnology sector. In the case of the biotech companies, a distinction wasonce again made between small and medium-sized companies (SME) having their headquarters inBavaria, and branch offices and subsidiaries of national and international biotech companies (biotechnologycompanies, non-SMEs). The term “non-SME” therefore does not say anything about the actual size of thisbranch office.The data forming the basis of this report are based on the evaluation of a written survey carried out byBioM Biotech Cluster Development GmbH at the beginning of 2012 of approx. 320 Life Science companiesthroughout Bavaria. Based on the questionnaires returned and intensive follow-up telephone calls it waspossible to achieve a response rate of almost 86%. Possible deviations from previously published figuresare the result of additional data obtained in this survey that also may refer to previous years. The periodunder review for this report is the year 2011.Published in April 20125
Page 2 and 3: Our research benefits your health.T
Page 6 and 7: Select IMGM as your outsourcing par
Page 8 and 9: The 2011 Biotech Year in Bavaria -A
Page 10 and 11: Due to this focus that was establis
Page 12 and 13: Furthermore, the continued interest
Page 14 and 15: Last but not least, the IZB start-u
Page 16 and 17: Company FoundationsMerck-Sharp & Do
Page 18 and 19: Total number of employees in the Ba
Page 20 and 21: PHASE II4SC: Hepatocellular carcino
Page 22 and 23: Deals, Cooperation, Mergers, Financ
Page 24 and 25: M&A-ActivityIn early 2011 the acqui
Page 26: Due to the increasing number of new
Page 29: one so called “innovation allianc
Page 32 and 33: 4SC AGBIOTECH THERAPEUTICS & DIAGNO
Page 34 and 35: Contact:Dr. Luc St-OngeFraunhoferst
Page 36 and 37: Contact:Dr. Lars WassillWerkstr. 2D
Page 38 and 39: Apceth GmbH & Co. KGBIOTECH THERAPE
Page 40 and 41: Contact:Dr. Gundel HagerBahnhofstr.
Page 42 and 43: Bernina Plus GmbHBIOTECH THERAPEUTI
Page 44 and 45: Biontex Laboratories GmbHBIOTECH DE
Page 46 and 47: Carl Zeiss MicroImaging GmbHBIOTECH
Page 48 and 49: ChemDiv, Inc.CROContact:Dr. Anna Ni
Page 50 and 51: conoGenetix biosciences GmbHBIOTECH
Page 52 and 53: CoreLab Partners Europe GmbHCROCont
Page 54 and 55:
Davids Biotechnologie GmbHBIOTECH D
Page 56 and 57:
Dynamic BiosensorsBIOTECH DNA/PROTE
Page 58 and 59:
Contact:Uschi LangGoethestr. 4D-803
Page 60 and 61:
Eurofins MWG OperonBIOTECH DNA/PROT
Page 62 and 63:
FGK Clinical Research GmbHCROContac
Page 64 and 65:
GeneArt AGBIOTECHContact:Prof. Dr.
Page 66 and 67:
Contact:Dr. Korbinian GroteBayerstr
Page 68 and 69:
Contact:Peter Paul SchikoraMühlfel
Page 70 and 71:
Contact:Kurt MartinJosef-Engert-Str
Page 72 and 73:
ibidi GmbHBIOTECH DEVICES & REAGENT
Page 74 and 75:
Immumed GmbH -Gesellschaft für ang
Page 76 and 77:
INHECO GmbHBIOTECH DEVICES & REAGEN
Page 78 and 79:
IRIS Biotech GmbHPHARMA & CHEMICAL
Page 80 and 81:
KLIFOVET AGCROContact:Dr. Klaus Hel
Page 82 and 83:
LEUKOCARE AGBIOTECH DEVICES & REAGE
Page 84 and 85:
medicomp GmbHCROContact:Dr. med. ve
Page 86 and 87:
Contact:Dr. Erwin SoutschekFlorians
Page 88 and 89:
MLL Münchner Leukämie Labor GmbHB
Page 90 and 91:
multimmune GmbHBIOTECH THERAPEUTICS
Page 92 and 93:
NanoScape AGPHARMA & CHEMICAL INDUS
Page 94 and 95:
nexttec GmbHBIOTECH DNA/PROTEIN ANA
Page 96 and 97:
Contact:Michael AlmstetterAm Klopfe
Page 98 and 99:
PAN Biotech GmbHBIOTECH DEVICES & R
Page 100 and 101:
Pharma Stulln GmbHPHARMA & CHEMICAL
Page 102 and 103:
Phytochem Referenzsubstanzen GbRmbH
Page 104 and 105:
PreSens Precision Sensing GmbHBIOTE
Page 106 and 107:
Contact:Dr. Torsten NeuefeindBunsen
Page 108 and 109:
Ridom GmbHBIOTECH BIOINFORMATICSCon
Page 110 and 111:
SERVIER Deutschland GmbHPHARMA & CH
Page 112 and 113:
SSS International Clinical Research
Page 114 and 115:
TILL Photonics GmbHBIOTECH DEVICES
Page 116 and 117:
Tripos InternationalBIOTECH BIOINFO
Page 118 and 119:
vertis Biotechnologie AGBIOTECH DNA
Page 120 and 121:
Wilex AGBIOTECH THERAPEUTICS & DIAG
Page 124:
Where the future becomes realityHOT
show all

Bavarian Biotech Report 2011/2012 (7MB) - Bio M

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?